Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Individualization of Ganciclovir and Valganciclovir in Renal Transplant Patients
NCT01446445Phase 4Completed
- Start
- Dec 2011
- Primary completion
- Aug 2014
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of ganciclovir, valganciclovir in cytomegalovirus infection (CMV). Started Dec 2011; status: completed.
02
Drugs
ganciclovirvalganciclovir
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT01446445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01446445.